Global Tumor Ablation Market by Manufacturers, Regions, Type and Application, Forecast to 2023

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.

Scope of the Report:
This report focuses on the Tumor Ablation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.
The classification of Tumor Ablation includes Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation and others. The proportion of Radiofrequency (RF) Ablation in 2015 is about 50.6%, and the proportion of Microwave Ablation in 2015 is about 21.7%.
Tumor Ablation is application in Liver Cancer, Lung Cancer, Kidney Cancer and Other cancers. The most proportion of Tumor Ablation is used in Lung Cancer, and the market share in 2015 is about 28.5%.
The worldwide market for Tumor Ablation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR () study.

Market Segment by Manufacturers, this report covers
Angiodynamics
Medtronic
Boston Scientific
Galil Medical
Neuwave Medical
Misonix
Merit Medical
Sonacare Medical
EDAP TMS

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies

Market Segment by Applications, can be divided into
Liver Cancer
Lung Cancer
Kidney Cancer
Others

There are 15 Chapters to deeply display the global Tumor Ablation market.
Chapter 1, to describe Tumor Ablation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Tumor Ablation, with sales, revenue, and price of Tumor Ablation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Tumor Ablation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Tumor Ablation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Tumor Ablation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source